This clinical trial is focused on patients undergoing major abdominal surgeries, such as esophagectomy, gastrectomy, colectomy, rectal resection, pancreatic resection, and hepatectomy. These procedures often involve significant bleeding, which may require blood transfusions. The study is investigating the use of Tranexamic Acid, a medication that helps reduce bleeding, to see if it can decrease the need for blood transfusions during and after these surgeries.
The purpose of the study is to determine if administering Tranexamic Acid during surgery can effectively reduce blood loss and the subsequent need for transfusions. Participants in the study will receive either the medication or a placebo. The treatment will be given through an intravenous infusion, which means it will be delivered directly into the bloodstream through a vein. The study will monitor the amount of blood loss, the number of blood transfusions needed, and any complications that may arise during the hospital stay.
In addition to Tranexamic Acid, the study will also use a solution called Sodium Chloride, commonly known as saline, which is often used in medical settings to maintain fluid balance. The trial aims to provide valuable information on how to better manage bleeding during major abdominal surgeries, potentially improving patient outcomes and reducing the need for blood transfusions.



Germany